US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

FEMY

Femasys (FEMY)

Femasys Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FEMY

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/18	21 : 30	GlobeNewswire Inc.	Femasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare Initiatives	NASDAQ:FEMY	Femasys Inc
2024/03/29	05 : 05	GlobeNewswire Inc.	Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update	NASDAQ:FEMY	Femasys Inc
2024/03/21	22 : 00	GlobeNewswire Inc.	Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape	NASDAQ:FEMY	Femasys Inc
2024/03/20	21 : 15	GlobeNewswire Inc.	Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility	NASDAQ:FEMY	Femasys Inc
2024/03/13	22 : 00	GlobeNewswire Inc.	Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024	NASDAQ:FEMY	Femasys Inc
2024/03/06	23 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/03/06	23 : 00	GlobeNewswire Inc.	Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	NASDAQ:FEMY	Femasys Inc
2024/02/28	23 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/02/14	11 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/14	11 : 44	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/06	22 : 47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2024/02/03	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/03	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2024/02/03	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/12/11	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FEMY	Femasys Inc
2023/12/08	23 : 28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FEMY	Femasys Inc
2023/12/01	07 : 17	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FEMY	Femasys Inc
2023/11/30	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/23	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/11/23	06 : 33	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/11/23	06 : 12	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:FEMY	Femasys Inc
2023/11/22	07 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/16	07 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/11/15	22 : 30	Business Wire	PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.	NASDAQ:FEMY	Femasys Inc
2023/11/02	10 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FEMY	Femasys Inc
2023/10/11	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/10/03	22 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/10/03	22 : 27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FEMY	Femasys Inc
2023/09/27	21 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc
2023/09/07	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FEMY	Femasys Inc

Showing the most relevant articles for your search:NASDAQ:FEMY

1 2 3 4 次へ >>

Gold vs US Dollar

Verizon Communications

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約